Sophia Genetics SAS
SOPHiA GENETICS is dedicated to transforming patient care through data-driven medicine by providing AI-powered, cloud-based solutions that analyze complex health data. Their platform, SOPHiA DDM™, connects a global network of healthcare institutions to deliver actionable insights for cancer, rare disorders, inherited diseases, and more, aiming to democratize access to precision medicine worldwide. The company offers solutions for genomics, radiomics, multimodal data analysis, and specialized applications such as hereditary cancer, blood cancers, solid tumors, and pharmacogenetics, supporting research and clinical workflows globally.
Industries
Nr. of Employees
large (251-1000)
Sophia Genetics SAS
Chemin des Aulx 12, 1228 Plan-les-Ouates, Geneva, Switzerland
Patents
Methods for asymmetric DNA library generation and optionally integrated duplex sequencing
US-12297490-B2
View DetailsMethods for detecting biallelic loss of function in next-generation sequencing genomic data
US-11830579-B2
View Details
Methods for asymmetric DNA library generation and optionally integrated duplex sequencing
US-12297490-B2
View DetailsMethods for detecting biallelic loss of function in next-generation sequencing genomic data
US-11830579-B2
View DetailsProducts
Cloud-based analytics platform for multimodal precision medicine
Cloud-native analytics platform that standardizes, analyzes and interprets genomic, imaging and clinical data using AI/ML to produce clinical and research insights.
NGS-based genomics applications for oncology and inherited disorders
Validated NGS applications and workflows for comprehensive genomic profiling, homologous recombination deficiency analysis, myeloid panels, hereditary cancer testing and liquid biopsy use cases.
Cloud-based analytics platform for multimodal precision medicine
Cloud-native analytics platform that standardizes, analyzes and interprets genomic, imaging and clinical data using AI/ML to produce clinical and research insights.
NGS-based genomics applications for oncology and inherited disorders
Validated NGS applications and workflows for comprehensive genomic profiling, homologous recombination deficiency analysis, myeloid panels, hereditary cancer testing and liquid biopsy use cases.
Services
Design and optimize NGS-based assays and algorithms for use in clinical trials, including analytical validation and implementation guidance.
End-to-end support for development, regulatory submission planning, and commercialization of NGS-based companion diagnostics.
Machine learning services that integrate genomic, imaging and clinical data to identify predictive signatures, perform patient stratification and support market access strategies.
On-site consultation, hands-on training, workflow optimization, sponsored testing programs and post-commercial adoption support to enable local testing capabilities.
Services and tooling to accelerate patient identification and enrollment by matching patient molecular profiles to relevant clinical trials.
Design and optimize NGS-based assays and algorithms for use in clinical trials, including analytical validation and implementation guidance.
End-to-end support for development, regulatory submission planning, and commercialization of NGS-based companion diagnostics.
Machine learning services that integrate genomic, imaging and clinical data to identify predictive signatures, perform patient stratification and support market access strategies.
On-site consultation, hands-on training, workflow optimization, sponsored testing programs and post-commercial adoption support to enable local testing capabilities.
Services and tooling to accelerate patient identification and enrollment by matching patient molecular profiles to relevant clinical trials.
Expertise Areas
- Multimodal AI-driven analytics
- Decentralized genomics networks and deployment
- NGS data analysis and variant interpretation
- Liquid biopsy and cfDNA longitudinal monitoring
Key Technologies
- Next-generation sequencing (NGS)
- Cell-free DNA (cfDNA) / liquid biopsy
- RNA-based and DNA-based fusion detection
- Low-pass whole genome sequencing (lpWGS) for HRD
News & Updates
Participation in the American Society of Pathology conference with updates on cancer research and solutions.
Event related to oncology and precision medicine.
Podcast series discussing how innovation is reshaping patient care.
Blog exploring DNA workflows for faster insights in myeloid malignancies.
2 Million Genomic Profiles Analyzed
Milestone in analyzing genomic data to support precision medicine.
Participation in the American Society of Pathology conference with updates on cancer research and solutions.
Event related to oncology and precision medicine.
Podcast series discussing how innovation is reshaping patient care.
Blog exploring DNA workflows for faster insights in myeloid malignancies.
2 Million Genomic Profiles Analyzed
Milestone in analyzing genomic data to support precision medicine.